AU6803694A - Cell growth regulators - Google Patents
Cell growth regulatorsInfo
- Publication number
- AU6803694A AU6803694A AU68036/94A AU6803694A AU6803694A AU 6803694 A AU6803694 A AU 6803694A AU 68036/94 A AU68036/94 A AU 68036/94A AU 6803694 A AU6803694 A AU 6803694A AU 6803694 A AU6803694 A AU 6803694A
- Authority
- AU
- Australia
- Prior art keywords
- cell growth
- growth regulators
- regulators
- cell
- growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/04—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amidines (3.5.4)
- C12Y305/04005—Cytidine deaminase (3.5.4.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939311252A GB9311252D0 (en) | 1993-06-01 | 1993-06-01 | Cell growth regualtors |
GB9311252 | 1993-06-01 | ||
PCT/GB1994/001190 WO1994027632A1 (en) | 1993-06-01 | 1994-06-01 | Cell growth regulators |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6803694A true AU6803694A (en) | 1994-12-20 |
Family
ID=10736425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU68036/94A Abandoned AU6803694A (en) | 1993-06-01 | 1994-06-01 | Cell growth regulators |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0703787A1 (en) |
JP (1) | JPH08510385A (en) |
AU (1) | AU6803694A (en) |
GB (1) | GB9311252D0 (en) |
NO (1) | NO954880L (en) |
WO (1) | WO1994027632A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2228378A1 (en) * | 1995-07-31 | 1997-02-13 | Centre De Recherche De L'hopital Sainte-Justine | Cytidine deaminase cdna as a positive selectable marker for gene transfer, gene therapy and protein synthesis |
US6905669B2 (en) | 2001-04-24 | 2005-06-14 | Supergen, Inc. | Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase |
JP2005508885A (en) | 2001-07-31 | 2005-04-07 | ザ ステイト オブ オレゴン, アクティング バイ アンド スルー ザ ステイト ボード オブ ハイヤー エデュケイション オン ビハーフ オブ ザ ユニバーシティー オブ オレゴン | Inhibitors of DNA methylation |
US6982253B2 (en) | 2002-06-05 | 2006-01-03 | Supergen, Inc. | Liquid formulation of decitabine and use of the same |
US7250416B2 (en) | 2005-03-11 | 2007-07-31 | Supergen, Inc. | Azacytosine analogs and derivatives |
US7700567B2 (en) | 2005-09-29 | 2010-04-20 | Supergen, Inc. | Oligonucleotide analogues incorporating 5-aza-cytosine therein |
JO2778B1 (en) | 2007-10-16 | 2014-03-15 | ايساي انك | Certain Compounds, Compositions and Methods |
CA2757744C (en) | 2009-04-06 | 2018-02-13 | Eisai Inc. | Combination of decitabine with cytidine deaminase inhibitor and use thereof in the treatment of cancer |
ES2628609T3 (en) | 2009-04-06 | 2017-08-03 | Otsuka Pharmaceutical Co., Ltd. | Combination of cytidine-based antineoplastic drugs with cytidine deaminase inhibitor and use thereof in the treatment of cancer |
US8324180B2 (en) | 2009-04-06 | 2012-12-04 | Eisai Inc. | Compositions and methods for treating cancer |
US8609631B2 (en) | 2009-04-06 | 2013-12-17 | Eisai Inc. | Compositions and methods for treating cancer |
MY163296A (en) | 2011-08-30 | 2017-09-15 | Astex Pharmaceuticals Inc | Drug formulations |
MX2018000016A (en) | 2015-07-02 | 2019-01-31 | Otsuka Pharma Co Ltd | Lyophilized pharmaceutical compositions. |
EP3661522A2 (en) | 2017-08-03 | 2020-06-10 | Otsuka Pharmaceutical Co., Ltd. | Drug compound and purification methods thereof |
-
1993
- 1993-06-01 GB GB939311252A patent/GB9311252D0/en active Pending
-
1994
- 1994-06-01 AU AU68036/94A patent/AU6803694A/en not_active Abandoned
- 1994-06-01 WO PCT/GB1994/001190 patent/WO1994027632A1/en not_active Application Discontinuation
- 1994-06-01 JP JP7500426A patent/JPH08510385A/en active Pending
- 1994-06-01 EP EP94916343A patent/EP0703787A1/en not_active Ceased
-
1995
- 1995-11-30 NO NO954880A patent/NO954880L/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO954880D0 (en) | 1995-11-30 |
WO1994027632A1 (en) | 1994-12-08 |
JPH08510385A (en) | 1996-11-05 |
GB9311252D0 (en) | 1993-07-21 |
NO954880L (en) | 1996-01-30 |
EP0703787A1 (en) | 1996-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4754393A (en) | Cell culture insert | |
AU4754493A (en) | Cell culture insert | |
AU4702593A (en) | Photovoltaic cell | |
AU2528292A (en) | Solar cell | |
AU673719B2 (en) | Twinning control | |
AU7338794A (en) | First stage scuba regulator | |
AU5050193A (en) | Sollar cell | |
AU1089995A (en) | Control of cell growth | |
AU4524293A (en) | Load cell | |
AU6138594A (en) | Electrochemical fulleren system | |
AU2536992A (en) | Solar cell | |
AU3773795A (en) | Electrochemical cell | |
AU7081094A (en) | Cell growth factor receptors | |
AU2709892A (en) | Solar cell | |
AU4410893A (en) | Electrolytic cell | |
AU6803694A (en) | Cell growth regulators | |
AU1185392A (en) | Solar cell | |
AU3752293A (en) | Photovoltaic cells | |
AU8196891A (en) | Mast cell growth factor | |
AU2608497A (en) | Novel neuronal cell growth factor | |
AU6188098A (en) | Plant growth regulator | |
AU4685497A (en) | Fluorine cell | |
AU5715394A (en) | Solar cell arrangement | |
AU4342993A (en) | Energy regulators | |
AU6630594A (en) | Electrolytic cell |